Mechanism and applications of CRISPR/Cas-9-mediated genome editing

M Asmamaw, B Zawdie - Biologics: targets and therapy, 2021 - Taylor & Francis
Clustered regularly interspaced short palindromic repeat (CRISPR) and their associated
protein (Cas-9) is the most effective, efficient, and accurate method of genome editing tool in …

[HTML][HTML] Advances in CRISPR therapeutics

M Chavez, X Chen, PB Finn, LS Qi - Nature Reviews Nephrology, 2023 - nature.com
The clustered regularly interspaced short palindromic repeats (CRISPR) renaissance was
catalysed by the discovery that RNA-guided prokaryotic CRISPR-associated (Cas) proteins …

[HTML][HTML] Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy

MF Rasul, BM Hussen, A Salihi, BS Ismael, PJ Jalal… - Molecular Cancer, 2022 - Springer
CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats-associated protein
9) shows the opportunity to treat a diverse array of untreated various genetic and …

Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges

M Asmamaw Mengstie - Frontiers in Bioengineering and …, 2022 - frontiersin.org
The Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) and its
accompanying protein (Cas9) are now the most effective, efficient, and precise genome …

Non-viral delivery of CRISPR–Cas9 complexes for targeted gene editing via a polymer delivery system

J O'Keeffe Ahern, I Lara-Sáez, D Zhou, R Murillas… - Gene therapy, 2022 - nature.com
Recent advances in molecular biology have led to the CRISPR revolution, but the lack of an
efficient and safe delivery system into cells and tissues continues to hinder clinical …

[HTML][HTML] Cas13d: a new molecular scissor for transcriptome engineering

R Gupta, A Ghosh, R Chakravarti, R Singh… - Frontiers in Cell and …, 2022 - frontiersin.org
The discovery of Clustered Regularly Interspaced Palindromic Repeats (CRISPR) and its
associated Cas endonucleases in bacterial and archaeal species allowed scientists to …

Therapeutic promise of engineered nonsense suppressor tRNAs

JJ Porter, CS Heil, JD Lueck - Wiley Interdisciplinary Reviews …, 2021 - Wiley Online Library
Nonsense mutations change an amino acid codon to a premature termination codon (PTC)
generally through a single‐nucleotide substitution. The generation of a PTC results in a …

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing

F Sinclair, AA Begum, CC Dai, I Toth… - Drug delivery and …, 2023 - Springer
The CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 genome
editing system has been a major technological breakthrough that has brought revolutionary …

[HTML][HTML] Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases

F Bigini, SH Lee, YJ Sun, Y Sun, VB Mahajan - Vision Research, 2023 - Elsevier
Gene therapy is a flourishing field with the potential to revolutionize the treatment of genetic
diseases. The emergence of CRISPR-Cas9 has significantly advanced targeted and efficient …

Role of CRISPR/Cas9 in the treatment of Duchenne muscular dystrophy and its delivery strategies

P Agrawal, V Harish, S Mohd, SK Singh, D Tewari… - Life Sciences, 2023 - Elsevier
Duchenne muscular dystrophy (DMD) is a neuromuscular disorder brought on by mutations
in the DMD gene, which prevent muscle cells from expressing the dystrophin protein …